Search Results
-
Elizabeth Mellins dies
Mellins, who studied autoimmune disease and co-founded a large pediatric rheumatology research network, was a tireless mentor and advocate for her field.
-
Hepatitis C treatment low
Antiviral medicine eliminates hepatitis C in 97% of patients, but Stanford Medicine researchers and colleagues find that many don’t receive the treatment.
-
‘Military police’ cells stem autoimmunity
A new study has identified a way that the immune system shoots down its own cells when their anti-viral activity threatens to become friendly fire. The finding could pave the way to new treatments for autoimmune diseases.
-
How Epstein-Barr virus triggers multiple sclerosis
A new study found that part of the Epstein-Barr virus mimics a protein made in the brain and spinal cord, leading the immune system to mistakenly attack the body’s nerve cells.
-
Common genetic profile linked to drug reaction
New medications help many people with inflammatory conditions and may ease severe COVID-19, but they carry risks.
-
Severe COVID-19, autoantibodies linked
A study spearheaded by Stanford researchers indicates that at least 1 in 5 hospitalized COVID-19 patients develops new antibodies that attack their own tissue within a week of admission.
-
COVID-19 hospitalizations among kids likely overcounted
Children being treated in hospitals are tested for SARS-CoV-2, but many who test positive never develop COVID-19 symptoms, leading to overestimates of disease severity, a study found.
-
New center for rare eye disease
A $10 million gift has enabled the launch of a center focusing on optic disc drusen, a poorly understood eye disease that can lead to visual impairment or even blindness.
-
Chronic fatigue syndrome biomarker found
Stanford scientists devised a blood-based test that accurately identified people with chronic fatigue syndrome, a new study reports.
-
Possible zinc strategy for diabetes
To treat diabetes directly, rather than manage its symptoms, doctors need a way to get drugs to cells that produce insulin. The key, Stanford researchers report, may be those cells’ affinity for zinc.